NYMXF Stock - Nymox Pharmaceutical Corporation
Unlock GoAI Insights for NYMXF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | $5,000 |
| Gross Profit | $-1,000 | $-11,000 | $-12,000 | $-12,000 | $-8,000 |
| Gross Margin | N/A | N/A | N/A | N/A | -160.0% |
| Operating Income | $-4,283,000 | $-8,350,000 | $-6,652,000 | $-12,504,000 | $-11,720,000 |
| Net Income | $-4,492,000 | $-8,844,000 | $-6,576,000 | $-12,537,000 | $-11,738,000 |
| Net Margin | N/A | N/A | N/A | N/A | -234760.0% |
| EPS | $-0.05 | $-0.10 | $-0.07 | $-0.15 | $-0.16 |
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.
Visit WebsiteEarnings History & Surprises
NYMXFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Jan 1, 2026 | — | — | — | — |
Q2 2025 | Jun 3, 2025 | — | $-0.01 | — | — |
Q4 2024 | Dec 27, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 29, 2024 | — | $-0.06 | — | — |
Q2 2024 | Jun 28, 2024 | — | — | — | — |
Q2 2024 | May 28, 2024 | — | $-0.06 | — | — |
Q4 2023 | Nov 15, 2023 | — | $-0.01 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 12, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 2, 2023 | — | $-0.01 | — | — |
Q3 2022 | Sep 29, 2022 | — | $-0.02 | — | — |
Q2 2022 | Jun 29, 2022 | — | $0.01 | — | — |
Q1 2022 | Mar 30, 2022 | — | $-0.06 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.03 | — | — |
Q3 2021 | Sep 29, 2021 | — | $-0.04 | — | — |
Latest News
Frequently Asked Questions about NYMXF
What is NYMXF's current stock price?
What is the analyst price target for NYMXF?
What sector is Nymox Pharmaceutical Corporation in?
What is NYMXF's market cap?
Does NYMXF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to NYMXF for comparison